European Xenical Report Estimates 20% Response Rate For Obesity Agent
Executive Summary
Approximately one-fifth of Xenical-treated patients lose 10% or more of their body weight after one year of therapy, the European Public Assessment Report for the anti-obesity agent orlistat states.